CHEBI:36704 - imiquimod

ChEBI IDCHEBI:36704
ChEBI Nameimiquimod
Stars
DefinitionAn imidazoquinoline fused [4,5-c] carrying isobutyl and amino substituents at N-1 and C-4 respectively. A prescription medication, it acts as an immune response modifier and is used to treat genital warts, superficial basal cell carcinoma, and actinic keratosis.
Last Modified17 April 2018
SubmitterMarcus Ennis
DownloadsMolfile
FormulaC14H16N4
Net Charge0
Average Mass240.310
Monoisotopic Mass240.13750
SMILESCC(C)Cn1cnc2c(N)nc3ccccc3c21
InChIInChI=1S/C14H16N4/c1-9(2)7-18-8-16-12-13(18)10-5-3-4-6-11(10)17-14(12)15/h3-6,8-9H,7H2,1-2H3,(H2,15,17)
InChIKeyDOUYETYNHWVLEO-UHFFFAOYSA-N
Wikipedia
Roles Classification
Applications:
antineoplastic agent  A substance that inhibits or prevents the proliferation of neoplasms.
interferon inducer  An agent that promotes the production and release of interferons.
ChEBI Ontology
Outgoing Relation(s)
imiquimod (CHEBI:36704) has role antineoplastic agent (CHEBI:35610)
imiquimod (CHEBI:36704) has role interferon inducer (CHEBI:36710)
imiquimod (CHEBI:36704) is a imidazoquinoline (CHEBI:38776)
IUPAC Name 
1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine
INNs  Source
imiquimodWHO MedNet
imiquimodWHO MedNet
imiquimodWHO MedNet
imiquimodumWHO MedNet
Synonyms  Source
1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amineIUPAC
4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinolineChemIDplus
R 837ChemIDplus
ImiquimodChemIDplus
Manual XrefsDatabases
ImiquimodWikipedia
DB00724DrugBank
LSM-5408LINCS
1429DrugCentral
AU2005320890Patent
EP1831219Patent
KR20070102652Patent
Registry NumbersSources
Reaxys:7710060Reaxys
CAS:99011-02-6ChemIDplus
Citations